205 related articles for article (PubMed ID: 11737987)
1. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
Ho PC; Saville DJ; Wanwimolruk S
J Pharm Pharm Sci; 2001; 4(3):217-27. PubMed ID: 11737987
[TBL] [Abstract][Full Text] [Related]
2. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
3. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
[TBL] [Abstract][Full Text] [Related]
4. Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice.
Edwards DJ; Bernier SM
Life Sci; 1996; 59(13):1025-30. PubMed ID: 8809221
[TBL] [Abstract][Full Text] [Related]
5. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products.
Ho PC; Saville DJ; Coville PF; Wanwimolruk S
Pharm Acta Helv; 2000 Apr; 74(4):379-85. PubMed ID: 10812937
[TBL] [Abstract][Full Text] [Related]
6. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
Bailey DG; Dresser GK; Kreeft JH; Munoz C; Freeman DJ; Bend JR
Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
8. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
Chan WK; Nguyen LT; Miller VP; Harris RZ
Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of 12 immature citrus fruit extracts for the inhibition of cytochrome P450 isoform activities.
Fujita T; Kawase A; Niwa T; Tomohiro N; Masuda M; Matsuda H; Iwaki M
Biol Pharm Bull; 2008 May; 31(5):925-30. PubMed ID: 18451520
[TBL] [Abstract][Full Text] [Related]
11. Identification of epoxybergamottin as a CYP3A4 inhibitor in grapefruit peel.
Wangensteen H; Molden E; Christensen H; Malterud KE
Eur J Clin Pharmacol; 2003 Feb; 58(10):663-8. PubMed ID: 12610742
[TBL] [Abstract][Full Text] [Related]
12. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
13. Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
Walker D; Flinois JP; Monkman SC; Beloc C; Boddy AV; Cholerton S; Daly AK; Lind MJ; Pearson AD; Beaune PH
Biochem Pharmacol; 1994 Mar; 47(7):1157-63. PubMed ID: 8161344
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
Dresser GK; Wacher V; Wong S; Wong HT; Bailey DG
Clin Pharmacol Ther; 2002 Sep; 72(3):247-55. PubMed ID: 12235445
[TBL] [Abstract][Full Text] [Related]
16. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
17. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction.
Fukuda K; Ohta T; Yamazoe Y
Biol Pharm Bull; 1997 May; 20(5):560-4. PubMed ID: 9178939
[TBL] [Abstract][Full Text] [Related]
18. Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
Li P; Callery PS; Gan LS; Balani SK
Drug Metab Dispos; 2007 Jul; 35(7):1203-8. PubMed ID: 17452418
[TBL] [Abstract][Full Text] [Related]
19. Synthetic models related to furanocoumarin-CYP 3A4 interactions. comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity.
Oda K; Yamaguchi Y; Yoshimura T; Wada K; Nishizono N
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1419-21. PubMed ID: 17827777
[TBL] [Abstract][Full Text] [Related]
20. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
Ohta T; Nagahashi M; Hosoi S; Tsukamoto S
Bioorg Med Chem; 2002 Apr; 10(4):969-73. PubMed ID: 11836106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]